Novo Pharm Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 12-07-2024
- Paid Up Capital ₹ 0.15 M
as on 12-07-2024
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 12-07-2024
- Revenue -24.01%
(FY 2020)
- Profit -138.62%
(FY 2020)
- Ebitda -145.66%
(FY 2020)
- Net Worth -7.14%
(FY 2020)
- Total Assets 10.07%
(FY 2020)
About Novo Pharm Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹1.00 M.
Ojasbhai Patel, Dhwani Patel, Jaikrishan Kotru, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231GJ1995PTC025060
- Company No.
025060
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Novo Pharm Formulations Private Limited offer?
Novo Pharm Formulations Private Limited offers a wide range of products and services, including Antibacterial Drugs, Ofloxacin Ornidazole Tablets, Anti Infective Agent, Cefpodoxime Proxetil Oral Suspension, Antibiotic Injection, Ceftriaxone Injection, Pantoprazole Drugs, Pantoprazole Tablets, Piperacillin Tazobactam Injection, Antibiotic Tablets & Capsules.
Who are the key members and board of directors at Novo Pharm Formulations?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ojasbhai Patel  | Director | 25-Oct-1999 | Current |
| Dhwani Patel | Director | 13-Dec-2021 | Current |
| Jaikrishan Kotru | Director | 27-Mar-2015 | Current |
| Ravjibhai Patel | Director | 09-Apr-2007 | Current |
Financial Performance and Corporate Structure Insights of Novo Pharm Formulations.
Novo Pharm Formulations Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 24.01% decrease. The company also saw a substantial fall in profitability, with a 138.62% decrease in profit. The company's net worth dipped by a decrease of 7.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novo Pharm Formulations?
In 2020, Novo Pharm Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Grand Mahi Club & Banquets Private LimitedActive 15 years 5 monthsOjasbhai Patel is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Baroda City Co - Operative Bank Limited Creation Date: 29 Dec 2011 | ₹0.40 M | Open |
The Baroda City Co - Operative Bank Limited Creation Date: 26 Dec 2011 | ₹0.60 M | Open |
How Many Employees Work at Novo Pharm Formulations?
Unlock and access historical data on people associated with Novo Pharm Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novo Pharm Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Pharm Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
